<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T08:42:46Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/126172" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/126172</identifier><datestamp>2025-12-05T12:27:42Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478916</setSpec><setSpec>col_2072_478917</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Severe Hyperammonemia In Late-onset Ornithine Transcarbamylase Deficiency Triggered By Steroid Administration</dc:title>
   <dc:creator>Gascón-Bayarri, Jordi</dc:creator>
   <dc:creator>Campdelacreu i Fumadó, Jaume</dc:creator>
   <dc:creator>Estela, Jordi</dc:creator>
   <dc:creator>Reñé Ramírez, Ramon</dc:creator>
   <dc:subject>Malalties rares</dc:subject>
   <dc:subject>Malalties cerebrals</dc:subject>
   <dc:subject>Rare diseases</dc:subject>
   <dc:subject>Brain diseases</dc:subject>
   <dc:description>Ornithine transcarbamylase deficiency (OTCD) is a rare X-linked disorder of urea synthesis leading to hyperammonemia. Several late-onset cases have been reported. Undiagnosed and untreated patients are at the risk of death or suffering from irreversible sequelae. We describe a 56-year-old patient who presented with acute encephalopathy after steroid treatment. Hyperammonemia due to OTCD was diagnosed and a mutation was found. This allowed us to diagnose two other family members with unexplained encephalopathy who are now asymptomatic on a low-protein diet. OTCD should be considered in any patient with hyperammonemic encephalopathy and immediate treatment should be given to avoid a fatal outcome. We emphasize the need to examine other family members if the diagnosis is confirmed, in order to prevent further life-threatening episodes of encephalopathy or neonatal coma of newborn.</dc:description>
   <dc:date>2018-11-16T09:49:15Z</dc:date>
   <dc:date>2018-11-16T09:49:15Z</dc:date>
   <dc:date>2015</dc:date>
   <dc:date>2018-07-24T12:35:22Z</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>https://hdl.handle.net/2445/126172</dc:identifier>
   <dc:identifier>25949836</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Reproducció del document publicat a: https://doi.org/10.1155/2015/453752</dc:relation>
   <dc:relation>Case Reports in Neurological Medicine, 2015, vol.</dc:relation>
   <dc:relation>https://doi.org/10.1155/2015/453752</dc:relation>
   <dc:rights>cc by (c) Gascón Bayarri et al., 2015</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/3.0/es/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>3 p.</dc:format>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Hindawi Ltd</dc:publisher>
   <dc:source>Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>